Elizabeth Geras-Raaka

Title: Elizabeth Geras-Raaka: Innovating in G Protein Coupled Receptor Research

Introduction

Elizabeth Geras-Raaka is a prominent inventor based in Dobbs Ferry, NY, whose contributions to the field of biochemistry focus on G protein coupled receptors (GPCRs). With a total of two patents to her name, her innovative approaches have the potential to greatly enhance our understanding and treatment of various conditions related to GPCR activity.

Latest Patents

Elizabeth's latest patents are groundbreaking in the identification of peptide agonists and negative antagonists of G protein coupled receptors. The first patent outlines a strategic method for discovering small peptides that can activate or inhibit GPCRs, utilizing combinatorial peptide libraries to screen a vast array of peptides. By tethering these peptides to a GPCR of interest, she has developed a system that allows for real-time monitoring to ascertain the peptide's efficacy as an agonist or negative antagonist.

Her second patent delves into a novel method for identifying negative antagonists for a constitutively active GPCR associated with human herpesvirus 8. This method employs co-expression with a reporter protein to assess the impact of various test substances. The potential applications of this research are significant, especially in the context of preventing tumor formation linked to active GPCRs.

Career Highlights

Elizabeth is affiliated with the Cornell Research Foundation Inc., where she applies her expertise in biochemistry to advance her research within the realm of GPCR functionality. Her contributions not only bolster scientific knowledge but also pave the way for therapeutic advancements that could fundamentally alter medical approaches to GPCR-related conditions.

Collaborations

Throughout her career, Elizabeth has collaborated with esteemed colleagues, including Marvin C. Gershengorn and Leandros Arvanitakis. These partnerships highlight her commitment to teamwork and interdisciplinary research, further enhancing the capabilities of her findings.

Conclusion

In summary, Elizabeth Geras-Raaka’s work exemplifies innovation in the biotechnology sector, particularly in the exploration of G protein coupled receptors. Her patents demonstrate creativity and a strategic approach to solving complex biological challenges, making her a significant figure in modern scientific research. As she continues to expand her contributions, the field can anticipate further groundbreaking discoveries that may have wide-reaching implications for medical science.